Magri, V., Scagnoli, S., Piesco, G., & Pomati, G. (2018). Lapatinib as second-line treatment after the double block pertuzumab-trastuzumab: a case report: Lapatinib in II linea dopo il doppio blocco pertuzumab-trastuzumab: un caso clinico. AboutOpen, 4(1), 185–190. https://doi.org/10.19156/abtpn.2018.0071